COLIZZI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 870
EU - Europa 345
AS - Asia 34
OC - Oceania 6
AF - Africa 3
SA - Sud America 1
Totale 1.259
Nazione #
US - Stati Uniti d'America 831
IT - Italia 137
IE - Irlanda 93
BE - Belgio 55
CA - Canada 34
DK - Danimarca 17
IN - India 10
DE - Germania 7
FI - Finlandia 7
TR - Turchia 7
ES - Italia 6
AT - Austria 4
CN - Cina 4
GB - Regno Unito 4
AU - Australia 3
ET - Etiopia 3
ID - Indonesia 3
IL - Israele 3
JO - Giordania 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
HU - Ungheria 2
MX - Messico 2
NL - Olanda 2
PH - Filippine 2
UA - Ucraina 2
AR - Argentina 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
FR - Francia 1
GR - Grecia 1
LK - Sri Lanka 1
NO - Norvegia 1
PL - Polonia 1
Totale 1.259
Città #
Chandler 250
Dublin 91
Princeton 84
Brussels 55
Ashburn 54
Toronto 32
Andover 30
Ogden 20
Copenhagen 16
Milan 15
Trieste 11
Rome 10
Udine 8
Istanbul 7
Chicago 6
Lonato 5
Ancona 4
Bergamo 4
Broomfield 4
Hanover 4
Hyderabad 4
Pune 4
Treia 4
Vienna 4
Alcantarilla 3
Auckland 3
Belgrade 3
Codroipo 3
Edinburgh 3
Helsinki 3
Jerash 3
Piacenza 3
Redmond 3
Spinea 3
Surabaya 3
Sydney 3
Treviso 3
Verona 3
Ahmedabad 2
Anglès 2
Arzignano 2
Budapest 2
Cagliari 2
Carmona 2
Dolo 2
Faenza 2
Gorizia 2
Groningen 2
Isola della Scala 2
Jerusalem 2
Laglio 2
Lappeenranta 2
Lubbock 2
Marmirolo 2
Monterrey 2
Ponte Lambro 2
Sammamish 2
Shenzhen 2
Turriaco 2
Villaricca 2
Buenos Aires 1
Cordovado 1
Cormeilles-en-Parisis 1
Dambulla 1
Desenzano del Garda 1
Durham 1
Edmonton 1
Kyjov 1
Madrid 1
Menlo Park 1
Minneapolis 1
Monfalcone 1
Nashville 1
New Orleans 1
New York 1
Nichelino 1
Nicosia 1
Oslo 1
Pasian di Prato 1
Porcia 1
Pyrbaum 1
Ruda 1
Seattle 1
Sorrento 1
Sorø 1
Tavagnacco 1
Tel Aviv 1
Volos 1
Warsaw 1
Wilmington 1
Zero Branco 1
Zurich 1
Totale 844
Nome #
Therapeutic Effect of Palmitoylethanolamide in Cognitive Decline: A Systematic Review and Preliminary Meta-Analysis of Preclinical and Clinical Evidence 46
The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends 43
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 43
Cannabis and cognition: Connecting the dots towards the understanding of the relationship 30
21.5 Repercussions of the First and Second COVID-19 Waves in the Italian Pediatric Population: An Inpatient Psychiatric Emergency Study 29
Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study 28
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 28
Cannabis use and the development of tolerance: a systematic review of human evidence 28
Feigning Capgras Syndrome and Developmental Prosopagnosia: a rare case of Pediatric Factitious Disorder 27
Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria 27
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains 27
4.4 IS ALTERED SENSORIMOTOR INTEGRATION A CORE FEATURE OF TOURETTE'S DISORDER? A CASE-CONTROL STUDY 26
Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration 26
The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System 26
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 25
51.18 THE COVID-19 OUTBREAK IMPACT ON WELL-BEING AMONG PEOPLE WITH AUTISM SPECTRUM DISORDER IN ITALY: AN N = 527 WEB-BASED SURVEY 25
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence 25
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids 25
Attachment styles in transsexual patients and clinical and nonclinical control groups: A Response 24
COGNITIVE DEFICITS AS INTERMEDIATE PHENOTYPE IN SCHIZOPHRENIA 24
Adolescent lifestyle behaviors, coping strategies and subjective wellbeing during the covid-19 pandemic: An online student survey 24
Cannabis: Neuropsychiatry and its effects on brain and behavior 24
Poster #35 STUDYING EPISODIC MEMORY CEREBRAL NETWORK: A NOVEL EVENT-RELATED TASK FOR FMRI 23
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis 23
Cannabis and psychosis: What do we know and what should we do? 23
Postural control in childhood: Investigating the neurodevelopmental gradient hypothesis 23
Hyperprolactinaemia in first episode psychosis - A longitudinal assessment 22
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence 22
Additional evidence for neuropsychiatric manifestations in mosaic trisomy 20: A case report and brief review 22
Investigating gait, movement, and coordination in children with neurodevelopmental disorders: Is there a role for motor abnormalities in atypical neurodevelopment? 21
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence 21
Differential gene expression analysis in blood of first episode psychosis patients 21
Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: A 2year follow-up study 21
Prevention in Mental Health: From Risk Management to Early Intervention 19
Confirmation of increased and more severe adolescent mental health-related in-patient admissions in the COVID-19 pandemic aftermath: A 2-year follow-up study 19
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis 19
Further evidence on the interplay between benzodiazepine and Z-drug abuse and emotion dysregulation 19
Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: A systematic review of human and animal evidence 18
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 17
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis 17
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis 16
Lo stigma nella salute mentale 16
The effect of cross-sex hormonal treatment on gender dysphoria individuals’ mental health: A systematic review 16
O3.4. DOES CANNABIS INDUCE PSYCHOSIS BY ALTERING GLUTAMATE SIGNALING IN THE STRIATUM? 15
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition 15
Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: Results from a longitudinal study 14
Poster #103 INTERACTION BETWEEN COMT GENOTYPE, CANNABIS USE, AND BFQ MEASURES OF SOCIABILITY 14
Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY 13
Epigenetic mediation of akt1 rs1130233′s effect on delta-9-tetrahydrocannabinol-induced medial temporal function during fear processing 13
Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021 13
Is there sufficient evidence that cannabis use is a risk factor for psychosis? 12
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 12
Mentalization in young patients undergoing opioid agonist treatment: Implications for clinical management 11
Epigenetic Regulation and Genetic Variation of AKT1 Predict Prefrontal Physiology 11
Vortioxetine Add-On to Methylphenidate for the Treatment of Symptoms of Sickness Behavior in Attention-Deficit Hyperactivity Disorder: Report of Two Cases 10
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 10
Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: A case-control study 10
Do cannabis users develop tolerance for the psychoactive effects of delta-9-tetrahydrocannabinol? An fMRI study 10
Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry 10
Gender-Oriented Mental Health Prevention: A Reappraisal 10
Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review 9
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults 9
Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example 9
Should we be concerned about stigma and discrimination in people at risk for psychosis? A systematic review 9
Evaluating psychobiological and mental distress in transsexualism before and after cross-sex hormonal treatment: Lesson learned from three longitudinal studies 9
Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis 9
Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing 9
Stigma as the main obstacle in health care and human rights among people with mental disorders. A rights-based ethics approach 9
Meet the Editorial Board Member 9
Changes in Revolving-Door Mental Health Hospitalizations during the COVID-19 Pandemic: A 5-Year Chart Review Study 9
Association between stressful life events and psychosis relapse: a 2-year prospective study in first-episode psychosis 8
Introduction 8
To treat or not to treat: Puberty suppression in childhood-onset gender dysphoria 8
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 8
The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task 8
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis 8
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A) 8
S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE 8
Editorial: Methods and applications in addiction psychiatry research: 2021 7
Psychosocial and behavioral impact of COVID-19 in autism spectrum disorder: An online parent survey 7
Neurocognitive effects of cannabis: Lessons learned from human experimental studies 7
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition 7
Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis 7
S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS 7
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use 7
Dissociative symptoms in individuals with gender dysphoria: Is the elevated prevalence real? 7
Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort 7
The effectiveness of lurasidone add-on for residual aggressive behavior and obsessive symptoms in antipsychotic-treated children and adolescents with tourette syndrome: Preliminary evidence from a case series 7
Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report 7
Effectiveness of equine-assisted activities and therapies for improving adaptive behavior and motor function in autism spectrum disorder 7
Risk of psychosis in autism spectrum disorder individuals exposed to psychosocial stressors: A 9-year chart review study 6
Psychological factors associated with vaccination hesitancy: an observational study of patients hospitalized for COVID-19 in a later phase of the pandemic in Italy 6
Editorial: Case reports in autism 6
Hormonal Treatment Reduces Psychobiological Distress in Gender Identity Disorder, Independently of the Attachment Style 6
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 6
Substance use, medication adherence and outcome one year following a first episode of psychosis 6
Prevention and early intervention in youth mental health: Is it time for a multidisciplinary and trans-diagnostic model for care? 6
Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol 6
Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior 6
Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure 6
Totale 1.549
Categoria #
all - tutte 14.704
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.704


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022463 0 0 0 0 0 0 92 175 0 0 41 155
2022/2023747 87 13 27 88 63 177 35 57 93 35 43 29
2023/2024389 42 45 15 12 87 20 37 90 41 0 0 0
Totale 1.599